France, July 1 -- The European Investment Bank (EIB) and Orano announced the signing of a €125 million credit line to finance the development of Orano Med and its industrial infrastructure, notably the construction of the Advanced Thorium Extraction Facility (ATEF), located in Bessines-sur-Gartempe, France.Orano Med, a subsidiary of the Orano group specializing in nuclear medicine, develops lead-212-based targeted alpha therapies, a new class of cancer treatments. By using the unique properties of alpha-emitter lead-212, these therapies aim at the targeted destruction of cancer cells, while limiting the impact on surrounding healthy tissue. Orano Med's clinical pipeline currently comprises four programs, run either independently or wi...